SE Inzucchi

825 total citations · 1 hit paper
6 papers, 670 citations indexed

About

SE Inzucchi is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, SE Inzucchi has authored 6 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 2 papers in Cardiology and Cardiovascular Medicine and 1 paper in Surgery. Recurrent topics in SE Inzucchi's work include Diabetes Treatment and Management (5 papers), Cardiovascular Function and Risk Factors (2 papers) and Diabetes Management and Research (2 papers). SE Inzucchi is often cited by papers focused on Diabetes Treatment and Management (5 papers), Cardiovascular Function and Risk Factors (2 papers) and Diabetes Management and Research (2 papers). SE Inzucchi collaborates with scholars based in Germany, Canada and United States. SE Inzucchi's co-authors include Matthias Nauck, Anne L. Peters, Απόστολος Τσάπας, RM Bergenstal, John B. Buse, Eleuterio Ferrannini, M. Diamant, Matthews Dr, Richard C. Wender and Jyothis T. George and has published in prestigious journals such as Diabetes Care and Diabetologie und Stoffwechsel.

In The Last Decade

SE Inzucchi

5 papers receiving 639 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379

2013 661 citations SE Inzucchi, RM Bergenstal et al. Diabetes Care profile →

Peers

SE Inzucchi

EDM

MB

SURGE

PHARM

EPIDE

Maria Yu United States

K. Jameson United Kingdom

Andreas Liebl Germany

Nor Azmi Kamaruddin Malaysia

Kotoba Okuyama Japan

Oliver Schnell Germany

Santiago Durán García Spain

Margaret Tiktin United States

M. E Miller United States

Tadeusz Dereziński Poland

Maria Yu United States

SE Inzucchi

623 ×1.0

EDM

294 ×1.3

MB

138 ×0.7

SURGE

107 ×1.8

PHARM

52 ×1.2

EPIDE

Citations per year, relative to SE Inzucchi SE Inzucchi (= 1×) peers Maria Yu

Countries citing papers authored by SE Inzucchi

Since Specialization

Citations

This map shows the geographic impact of SE Inzucchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SE Inzucchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SE Inzucchi more than expected).

Fields of papers citing papers by SE Inzucchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SE Inzucchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SE Inzucchi. The network helps show where SE Inzucchi may publish in the future.

Co-authorship network of co-authors of SE Inzucchi

This figure shows the co-authorship network connecting the top 25 collaborators of SE Inzucchi. A scholar is included among the top collaborators of SE Inzucchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with SE Inzucchi. SE Inzucchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Mattheus, Michaela, Naveed Sattar, Ivana Ritter, et al.. (2021). Cardiovascular and kidney implications of the initial response in estimated glomerular filtration rate to sodium glucose cotransporter-2 inhibition with empagliflozin: the ‘eGFR dip’ in EMPA-REG OUTCOME. Diabetologie und Stoffwechsel. 16.

2.

Inzucchi, SE, Christoph Wanner, Uwe Hehnke, et al.. (2019). Composite retinopathy outcome in patients treated with empagliflozin versus placebo in the EMPA-REG OUTCOME trial. Diabetologie und Stoffwechsel. 1 indexed citations

3.

Inzucchi, SE, et al.. (2018). Reduction in cardiovascular death with empagliflozin is consistent across categories of baseline HbA1c and change in HbA1c: Results from EMPA-REG OUTCOME. Diabetologie und Stoffwechsel. 3 indexed citations

4.

Fitchett, David, et al.. (2018). Empagliflozin reduces heart failure irrespective of control of blood pressure, low density lipoprotein cholesterol and HbA1c. Diabetologie und Stoffwechsel. 4 indexed citations

5.

Zinman, Bernard, et al.. (2017). Consistent effect of empagliflozin on cardiovascular death in subgroups by type of cardiovascular disease: results from EMPA-REG OUTCOME. Diabetologie und Stoffwechsel. 12(S 01). S1–S84. 1 indexed citations

6.

Inzucchi, SE, RM Bergenstal, John B. Buse, et al.. (2013). Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379. Diabetes Care. 36(2). 490–490. 661 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact